Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tigason improved hair growth in a boy with monilethrix without side effects.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Ritlecitinib is an effective new treatment for Alopecia Areata.

New compounds were developed that promote hair growth in mice.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Cancer treatments often cause skin, nail, and hair problems.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.